This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Philipp Wenter, Ph.D.
Senior Director of Drug Substance Manufacturing, Technical Operations at Apellis Pharmaceuticals


Dr. Philipp Wenter is Senior Director of Drug Substance Manufacturing at Apellis Pharmaceuticals. Before that Dr. Wenter held the position of VP of Manufacturing at Eurofins Genomics and Director of Process Development and R&D at Operon Biotechnologies. He has extensive experience in developing and optimizing manufacturing processes for automated synthesis and purification of large synthetic biomolecules from early development to commercialization. 

Dr. Wenter obtained his diploma in Chemistry in 2001 from the University of Innsbruck and a PhD in the field of Bioorganic Synthesis form the EPFL in Lausanne in 2006.

Agenda Sessions

  • Pegcetacoplan – How an Efficient and Cost-Effective Commercial Manufacturing Process for a PEG-ylated Peptide Can Be Implemented at the Ton Scale?